Simple blood test could tell doctors if cancer treatment is failing
NCT ID NCT05426668
Summary
This study is testing a new blood test to see if it can predict whether immunotherapy will work for patients with advanced lung cancer. Researchers will track 170 patients receiving standard immunotherapy to see if changes in tumor DNA in their blood can signal treatment failure earlier than current scans. The goal is to give doctors a tool to identify non-responders quickly so they can try other treatments sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medizinische Hochschule Hannover
RECRUITINGHanover, 30625, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pius-Hospital Oldenburg
RECRUITINGOldenburg, 26121, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Medical Center Göttingen
RECRUITINGGöttingen, Lower Saxony, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.